24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's
RecruitingNCT06570421Phase: NAStarted 2024-07-19
Summary
This study investigates the long-term safety and tolerability of home peroneal eTNM® therapy using the URIS I™ device in subjects with Parkinson's disease (PD) or Essential Tremor (ET). Previously, a
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Cerebrovaskulární poradna s.r.o.Ostrava, Czechia
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06570421